Geode Capital Management, LLC Immuno Precise Antibodies Ltd. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Geode Capital Management, LLC holds 10,668 shares of IPA stock, worth $3,627. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,668
Previous 17,484
38.98%
Holding current value
$3,627
Previous $11,000
63.64%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IPA
# of Institutions
20Shares Held
1.91MCall Options Held
0Put Options Held
0-
Ingalls & Snyder LLC New York, NY1.56MShares$530,8520.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny78.2KShares$26,5880.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$14,0080.0% of portfolio
-
Northern Trust Corp Chicago, IL41.1KShares$13,9760.0% of portfolio
-
Bank Of Montreal Toronto, A635.3KShares$12,0040.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $8.44M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...